Ebola fears could buoy Halyard Health’s public debut
Kimberly-Clark Worldwide Inc.
JNJ/Synthes integration continues to bring hefty charges | The week in medtech M&A
Kimberly-Clark plans to spin out Halyard Health as a separately traded company | Medtech Wall Street news for the week of October 13, 2014
ConvaTec owners appoint banks to explore sale: sources
(Reuters) – ConvaTec‘s owners have appointed Morgan Stanley and Goldman Sachs to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said.
Kimberly-Clark to spin out Halyard Health Oct. 31
Second suitor cedes the field early to Zimmer | Medtech Wall Street news for the week of September 15, 2014
Second suitor cedes the field early to Zimmer | The week in medtech M&A
Kimberly-Clark readies Halyard Health medical device spinout
Analyst speculates Smith & Nephew split | Medtech Wall Street news for the week of Mar. 31, 2014
Baxter reveals plans to split pharma, medical products businesses
Kimberly-Clark hits 52-week high on news of medical device spinout
Kimberly-Clark (NYSE:KMB) said it’s planning to spin out its medical device and health products division as a separate public company, prompting investors to bid its stock up to a 52-week high yesterday and even higher today in pre-market trading.
